References
- PDQ Screening and Prevention Editorial BoardColorectal cancer screening (PDQ®): health professional versionPDQ Cancer Information SummariesBethesda, MDNational Cancer Institute2002
- JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin201161 69 9021296855
- YatsuokaTNishimuraYSakamotoHTanakaYKurozumiMLymph node metastasis of colorectal cancer with submucosal invasionGan To Kagaku Ryoho201340 2041 2043 Japanese24394006
- ShiYHuangXXChenGBDragon (RGMb) induces oxaliplatin resistance in colon cancer cellsOncotarget20167 48027 4803727384995
- WiegeringAMatthesNMuhlingBReactivating p53 and inducing tumor apoptosis (RITA) enhances the response of RITA-sensitive colorectal cancer cells to chemotherapeutic agents 5-fluorouracil and oxaliplatinNeoplasia201719 301 30928284059
- OnozawaHSaitoMSaitoKAnnexin A1 is involved in resistance to 5-Fu in colon cancer cellsOncol Rep201737 235 24027840982
- NegiASKumarJKLuqmanSShankerKGuptaMMKhanujaSPRecent advances in plant hepatoprotectives: a chemical and biological profile of some important leadsMed Res Rev200828 746 77217979145
- MalahubbanMAlimonARSaziliAQFakuraziSZakryFAPhytochemical analysis of Andrographis paniculata and Orthosiphon stamineus leaf extracts for their antibacterial and antioxidant potentialTrop Biomed201330 467 48024189677
- WenLXiaNChenXActivity of antibacterial, antiviral, anti-inflammatory in compounds andrographolide saltEur J Pharmacol2014740 421 42724998876
- KhanASharmaPKhanFAjayakumarPVShankerKSamadAIn silico and in vitro studies on Begomovirus induced andrographolide biosynthesis pathway in Andrographis paniculata for combating inflammation and cancerMol Inform201635 253 26127492239
- ZhangMXueEShaoWAndrographolide promotes vincristine-induced SK-NEP-1 tumor cell death via PI3K-AKT-p53 signaling pathwayDrug Des Devel Ther201610 3143 3152
- MiSXiangGYuwenDInhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathwayToxicol Appl Pharmacol2016310 78 8627639426
- BanerjeeAAhmedHYangPCzinnSJBlanchardTGEndoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatmentOncotarget20167 41432 4144427166181
- WangWGuoWLiLAndrographolide reversed 5-Fu resistance in human colorectal cancer by elevating BAX expressionBiochem Pharmacol2016121 8 1727693317
- ChouTCTalalayPQuantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdv Enzyme Regul198422 27 556382953
- ChouTCDrug combination studies and their synergy quantification using the Chou–Talalay methodCancer Res201070 440 44620068163
- ChouTCPreclinical versus clinical drug combination studiesLeuk Lymphoma200849 2059 208019021049
- CummingsBSSchnellmannRGMeasurement of cell death in mammalian cellsCurr Protoc Pharmacol200412 12 18
- NguyenVPKimSWKimHBiocompatible astaxanthin as a novel marine-oriented agent for dual chemo-photothermal therapyPLoS One2017124 e017468728369126
- TemrazSMukherjiDAlameddineRShamseddineAMethods of overcoming treatment resistance in colorectal cancerCrit Rev Oncol Hematol201489 217 23024075059
- EngelmanJAZejnullahuKMitsudomiTMET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingScience2007316 1039 104317463250
- BirchmeierCBirchmeierWGherardiEVande WoudeGFMet, metastasis, motility and moreNat Rev Mol Cell Biol20034 915 92514685170
- PomerleauVLandryMBernierJVachonPHSaucierCMet receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functionsBMC Cancer201414 24024708867
- BernierJChababiWPomerleauVSaucierCOncogenic engagement of the Met receptor is sufficient to evoke angiogenic, tumorigenic, and metastatic activities in rat intestinal epithelial cellsAm J Physiol Gastrointest Liver Physiol2010299 G677 G68620539003